"He was traded from the Diamondbacks to the Brewers at the trade deadline but had to undergo Tommy John surgery in September. When healthy, Miller has shown a great deal of potential. He was fantastic in 2023 with the Dodgers, although his stint with the Tigers in 2024 was not ideal. Nonetheless, the metrics from his 46.0 innings in 2025 were very impressive, making this a high-upside deal for when he returns to the mound."
"Because he underwent surgery in September, the odds of him pitching for the 2026 Cubs are extremely low. That is the reasoning behind this being a multi-year deal. The Cubs and their pitching lab are able to keep Miller in the organization while he rehabs, with the goal of having him on the roster in 2027, if baseball is played that year."
Chicago Cubs are nearing a multi-year deal with reliever Shelby Miller. Miller appeared in 48 games in 2025, posting a 2.74 ERA and a 35.8 percent chase rate. He was traded from the Diamondbacks to the Brewers at the trade deadline and underwent Tommy John surgery in September. Miller showed strong performance in 2023 with the Dodgers, while his 2024 stint with the Tigers was subpar. Metrics from his 46.0 innings in 2025 were impressive, making the contract a high-upside gamble. The surgery makes a 2026 return unlikely, and the multi-year structure facilitates rehab within the Cubs organization and targets 2027 availability.
Read at Cubsinsider
Unable to calculate read time
Collection
[
|
...
]